Discover 603 paid clinical trials in Bellevue, Nebraska. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 603
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
for
Cystic Fibrosis
Location: Omaha NE, Kansas City KS, Minneapolis MN, St Louis MO,
Sponsor: Nicole Hamblett
Sex: All
Age: 12+
Code: NCT06504589
Recruiting
Intranasal Oxytocin Intervention for Caregivers to Persons With Dementia
for
Stress
Location: Omaha NE
Sponsor: University of Nebraska
Sex: Female
Age: 50+
Code: NCT06364228
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
for
B-cell Mediated Autoimmune Disorders
Location: Omaha NE, Milwaukee WI, Ann Arbor MI, Columbus OH,
Sponsor: TG Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06680037
Phase1, Recruiting
PULSED AF Post-Approval Study
for
Atrial Fibrillation
Location: Omaha NE, Chicago IL, Cincinnati OH, Grove City OH,
Sponsor: Medtronic Cardiac Ablation Solutions
Sex: All
Age: 18+
Code: NCT06578104
Recruiting
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
for
Pulmonary Hypertension Associated With HFpEF
Location: Omaha NE, Peoria IL, Marshfield WI, Indianapolis IN,
Sponsor: Tenax Therapeutics, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07288398
Phase3, Recruiting
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
for
Generalized Myasthenia Gravis
Location: Omaha NE, Oklahoma City OK, Yukon OK, Schaumburg IL,
Sponsor: Immunovant Sciences GmbH
Sex: All
Age: 18 - 70+
Code: NCT07039916
Phase3, Recruiting
New
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
for
Type 2 Diabetes, Cardiovascular Risk
Location: Council Bluffs IA, Omaha NE, Topeka KS, St Louis MO,
Sponsor: Novo Nordisk A/S
Sex: All
Age: 45+
Code: NCT07797335
Phase3, Recruiting
New
Enteral Nutrition Versus Standard of Care in Allogeneic Hematopoietic Stem Cell Transplantation
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
for
Relapsed Hematologic Malignancy,
Location: Omaha NE, Rochester MN, Chicago IL, Cleveland OH,
Sponsor: Curis, Inc.
Sex: All
Age: 18+
Code: NCT03328078
Phase1, Phase2, Recruiting
A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer
for
HER2-positive Gastric Cancer,
Location: Omaha NE, Burnsville MN, St Louis MO, Hinsdale IL,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06764875
Phase3, Recruiting
SAD and MAD of Inhaled AR-501 in Health Adults and P. Aeruginosa Infected Cystic Fibrosis Subjects
for
Cystic Fibrosis
Location: Omaha NE, Iowa City IA, Oklahoma City OK, Chicago IL,
Sponsor: Aridis Pharmaceuticals, Inc.
Sex: All
Age: 18 - 49
Code: NCT03669614
Phase1, Phase2, Recruiting
Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy
Location: Omaha NE, Iowa City IA, St Louis MO, Lexington KY,
Sponsor: RayzeBio, Inc.
Sex: All
Age: 18+
Code: NCT05477576
Phase3, Recruiting
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
for
Metastatic Clear Cell Renal Cell Carcinoma,
Location: Omaha NE, Rochester MN, St Louis MO, Zion IL, Aurora CO,
Sponsor: Arcus Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT07011719
Phase3, Recruiting
Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation
for
Delayed Graft Function, DGF, Kidney Transplant
Location: Omaha NE, Fairway KS, Minneapolis MN, St Louis MO,
Sponsor: Alexion Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT06830798
Phase3, Recruiting
Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC